The topic of losing weight with Ozempic often carries an undertone of criticism, with many quick to label it as the "easy way out." But it is not the easy way out. It's the correct way. Forget calories, hormones rule.
Jillian Michaels who became popular because of the Biggest Loser” was Bill Maher’s guest on his April 19th show. This hit TV series recruited contestants with messed up bodies and minds who became even more messed up as a result of Jillian’s diet and exercise abuse. True there was weight loss, but most of it was reversed and even metabolism was adversely affected. Jillian Michaels’ denigrates Ozempic because her business is selling “go for the burn” exercise and “ eat healthy” dieting which leads to binging. How do we know this? FaceBook Ozempic Support Group chat says the medicine fixes hunger so now many can barely finish two slices of PIZZA when they used to devour an entire pie!!
In addition to the 65% of the U.S. population who are obese, there are now FIVE official eating disorders and 22 % of young people are “eating disordered.” Still Americans continue to mouth the failed formula. We were easily suckered into counting calories and buying thousands of dopey diets and then doing painful “fat burning “exercises.
In addition to obesity, our population includes 100 million with Fatty Liver disease; 96 million with Metabolic Syndrome; and 50 million with Diabetes. Of course, we made lots of dough--$trillions is what wellness brings to the economy. These riches may not continue because consumers are fleeing abusive programs and over consumption. The CEO of Walmart has been quoted as saying that customers taking Ozempic buy fewer groceries. Fewer steaks and fewer bags of potato chips . Fewer popsicles and fewer bags of kale.
So 15 years ago when Meredith Luce MS RD LN who has more degrees in nutrition than a thermometer said “Forget Calories. Hormones Rule” no one understood her comment because it was before scientists had figured out exactly how to fix the problem of unbalanced hormones which has led to ravenous hunger. The GLP-1 drugs take the ravenous hunger and downsizes it. Then your body downsizes and then everything starts to work properly. We now know that the real issue extends beyond mere calorie counting to the hormonal imbalances that drive insatiable hunger—a condition often misunderstood and mislabeled simply as a lack of willpower.
Today Ozempic addresses this core issue by regulating hormonal misfires, reducing the overwhelming hunger that can make permanent weight loss seem impossible. It’s not merely a workaround, but a legitimate, medically-supported pathway to better health and happiness.
Moreover, the implications of hormonal treatments extend beyond weight loss. Preliminary research shows benefits in other areas such as addiction management and even slowing the progression of diseases like Parkinson’s. And sleep apnea and strokes from high blood pressure, etc. will be reduced too.
YOUR comment is why 65% of Americans are fat and 100 mil have FATTY Liver; 96 mil have Metabolic Syndrome and 50 mil have diabetes and all of them are unsexy and unsophisticated too.
Actually, Ozempic acts on the endocannabinoid system to quiet excessive inflammatory cell signalling. Excerpt: "Endocannabinoids and their G-protein coupled receptors (GPCR) are a current research focus in the area of obesity due to the system's role in food intake and glucose and lipid metabolism. Importantly, overweight and obese individuals often have higher circulating levels of the arachidonic acid-derived endocannabinoids anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) and an altered pattern of receptor expression. Consequently, this leads to an increase in orexigenic stimuli, changes in fatty acid synthesis, insulin sensitivity, and glucose utilisation, with preferential energy storage in adipose tissue." https://pubmed.ncbi.nlm.nih.gov/23762050/
The problem is too much arachidonic acid in the food supply and not enough of the omega-3s. https://pubmed.ncbi.nlm.nih.gov/33914036/
Norwegian animal scientists explain how to efficiently quiet excessive cell signaling without having to resort to drugs. " Because arachidonic acid (AA) competes with EPA and DHA as well as with LA, ALA and oleic acid for incorporation in membrane lipids at the same positions, all these fatty acids are important for controlling the AA concentration in membrane lipids, which in turn determines how much AA can be liberated and become available for prostaglandin biosynthesis following phospholipase activation. Thus, the best strategy for dampening prostanoid overproduction in disease situations would be to reduce the intake of AA, or reduce the intake of AA at the same time as the total intake of competing fatty acids (including oleic acid) is enhanced, rather than enhancing intakes of EPA and DHA only. Enhancement of membrane concentrations of EPA and DHA will not be as efficient as a similar decrease in the AA concentration for avoiding prostanoid overproduction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875212/